UnitedHealth Group reported strong first-quarter revenues and earnings driven by Optum's performance. However, the outlook was tempered by concerns over Medicare Advantage margin pressures due to rate cuts and sequestration. While the growth prospects remain positive, the cautious guidance may neutralize any immediate positive stock movement.

[0]